Non-separation fluoroimmunoassays are well suited to automation. The potential sensitivity of such assays has not been realised because the most commonly used label (fluorescein) has absorption and emission spectra which coincide with those of blood constituents and because it has a very small Stokes shift. Lucifer yellow VS has a larger Stokes shift than fluorescein and an emission maximum at longer wavelength. We describe an energy transfer fluoroimmunoassay for plasma albumin in which Lucifer yellow VS is used to label albumin and rhodamine B isothiocyanate is used to label anti-albumin antibodies. The assay shows good correlation with a dye-binding method for albumin and has sensitivity and precision which compare favourably with similar assays using a fluorescein label.
Energy transfer immunoassay: antigen (Ag) is labelled with a fiuorophore Fl having an emission maximum at a wavelength Ai' Antibodies (Ab) are labelled with another fiuorophore, Fl, having an excitation maximum at or close to Ai and an emission maximum at wavelength Aa.
Excitation at wavelength Au. the excitation maximum of Fl, causes emission at wavelength Ai from free antigen. Binding ofAg to Ab brings Fl and Fl into close proximity, allowing energy transfer to take place by a dipole-dipole interaction and causing quenching of the emission of Fl and enhancement of the emission of Fl.
The ETTA originally described by Ullman and coworkers? was developed using fluorescein-labelled antigen and antibodies labelled with rhodamine. However, where fluorescein is used to label the antigen, interferences arise because of the intrinsic fluorescence of the sample and because excitation at 495 nm leads to considerable direct excitation of the label attached to the antibody, resulting in a high background fluorescence. More recently, Thakrar and Miller" and Miller, Lim, and Bridges'' have reported the use of fluorescein and eosin, quinacrine and eosin, and fluorescamine and fluorescein, as pairs of labels for ETTA. Substitution A major disadvantage of radioimmunoassay (RIA) is the inevitable requirement for some form of physical separation of free and antibody-bound labelled antigen before radioactive counting. This separation step is a source of imprecision and has proved to be an obstacle to the development of automated systems for RIA. Fluorescent labels, unlike radioactive labels, are often sensitive to changes in their immediate environment, and while this can be a disadvantage in some respects, it has been exploited in the development of several types of homogeneous fluoroimmunoassay (PIA). The simplest of these rely on quenching-or enhancernent'' of fluorescence when a labelled antigen binds to its antibody, an effect which is, however, unpredictable and relatively uncommon. More generally applicable types of assay have been developed in which changes in fluorescence polarisation on binding to antibody are measureds: in which fluorescence is quenched by antibodies to the fluorophore (indirect quenching! or fluorescence protections immunoassay and alternative binding" immunoassay); and in which fluorescence is quenched on binding of labelled antigen to an antibody which is labelled with a second chromophore (energy transfer immunoassay, ETTA?-see Fig. I ). Fluorescence polarisation immunoassay and alternative binding FIA are suitable for the measurement of small molecules, whereas indirect quenching immunoassay is more suitable for the measurement of large antigens. Energy transfer immunoassay is potentially applicable to the measurement of both large and small molecules.~A g~õ jO S9 of fluorescamine or quinacrine for fluorescein reduces the extent of direct excitation of the second label but does so at the expense of increased intrinsic fluorescence of the sample.
Lucifer yellow VS has an emission maximum at 540 nm, which gives excellent overlap with the absorption maximum of rhodamine B at 550 nm. In addition, the absorption maximum of Lucifer yellow VS, at 430 nm, is sufficiently far removed from that of rhodamine B to reduce direct excitation of the rhodamine B to an acceptable level. We have previously'? described the use of Lucifer yellow VS in a heterogeneous FIA for human albumin, using polyethylene glycol for separation of bound and free fractions. In this paper we describe an energy transfer immunoassay for human albumin in which Lucifer yellow VS is used to label the antigen and rhodamine B isothiocyanate is used to label antialbumin antibodies.
Materials and methods
Except where otherwise stated, reagents were obtained from BDH Chemicals Ltd, Poole, Dorset BHI24NN.
Lucifer yellow VS was a gift from Aldrich Chemical Co Ltd, The Old Brickyard, New Road, Gillingham, Dorset SP8 4JL. (Lucifer yellow VS is now commercially available.)
Human albumin, crystallised and Iyophilised, and goat anti-human-albumin, dialysed and fractionated serum, were obtained from Sigma Chemical Co Ltd, Fancy Road, Poole, Dorset BHl7 7NH.
Dimethyl sulphoxide, puriss, was obtained from Koch Light Laboratories Ltd, Colnbrook, Bucks.
PREPARATION OF LABELLED ALBUMIN AND LABELLED ANTI-ALBUMIN
Human albumin was labelled with Lucifer yellow VS as previously described.P Human albumin (10 gil, 0·5 ml), Lucifer yellow VS (1 gil, 0·5 ml), and sodium bicarbonate (0·2 mol/l, I ml) were mixed and allowed to stand for 2 to 4 hours, and the labelled albumin was purified by passage through a small column of Sephadex G25 (Pharmacia Ltd, Prince Regent Road, Hounslow, Middx TW3 1NE).
Anti-albumin antiserum was labelled with rhodamine B by a modification of the method described'! for the preparation of fluorescein-labelled antibodies for immunofluorescence studies. Rhodamine B isothiocyanate, about I mg, was dissolved in dimethyl sulphoxide to give a concentration of 4 gil. Antiserum was reconstituted according to the manufacturer's instructions and divided into O·I ml aliquots. Unused antiserum was stored at -20°C. For labelling, an aliquot of 0·1 ml was diluted with 1 ml of 0·1 mol/l disodium hydrogen phosphate to give a solution containing about 6 mg protein. Rhodamine B isothiocyanate in DMSO (180 fl.1) was added dropwise to the protein solution with continuous mixing, and the reaction mixture was allowed to stand in the dark at room temperature for 2 to 4 hours. The mixture was centrifuged briefly to remove some precipitated protein and applied to a 2 x 6 ern column of Sephadex G25 equilibrated with 0·1 mol/l tris-(hydroxymethyl) methylamine (tris) buffer, pH 8·7. The column was eluted with 0·1 mol/l tris buffer, pH 8.7, and the first coloured band (about 3 ml) was collected.
ANTIBODY DILUTION CURVE
Doubling dilutions of the labelled antiserum were prepared in O· 1 mol/I tris buffer, pH 8·7. Luciferlabelled albumin, 0·1 ml, was diluted with 20 ml 0·1 rnol/l tris buffer, pH 8·7. To 0·1 ml of each dilution in 2·5 ml round-bottomed polystyrene tubes (Luckham Ltd, Victoria Gardens, Burgess Hill, Sussex) was added O·1 ml of 0·1 moljl phosphate buffer, pH 7, and 0·1 ml labelled albumin. A duplicate set of tubes was prepared containing o· I ml of 0·1 moljl tris buffer, pH 8·7, instead of the labelled albumin. The reaction mixtures were incubated in the dark at room temperature for 3 to 4 hours, and 1 ml of 0·1 moljl tris buffer, pH 8·7, was added to each tube. The mixtures were diluted 1 in 4 in 0·2 % aqueous Triton X-IOO in a simple continuous-flow system (Fig. 2 ) and the fluorescence intensity was measured at 540 nm using a Hitachi Perkin-Elmer MPF-3L spectrofluorimeter (Perkin-Elmer Ltd, Post Office Lane, Beaconsfield, Bucks HP9 IQA). Instrument settings were: excitation wavelength 430 nm; emission wavelength 540 nm; Figure 4 . The fluorescence intensities of the highest and lowest standards differ by a factor of about 3. Figure 5 shows the comparison between the ETIA and the manual dye-binding method. For 20 samples the correlation coefficient is 0·98 and the slope of the regression line is 1·1. Within-batch precision was assessed on 30 replicate samples of a plasma specimen; the coefficient of variation was 3·8 % at 50 g/1. instrument sensitivity 30; excitation bandwidth 40 nm; emission bandwidth 18 nm. A 520 nm cut-off filter was placed in the emission light path.
FLUOROIMMUNOASSAY OF ALBUMIN
Standards containing 19 to 625 mg/I of albumin were prepared by doubling dilutions from a stock solution containing 10 g/1. These were equivalent to plasma concentrations of 7·8 to 250 g/I when the initial dilution of plasma for assay was taken into account. The working standards were stored in 0·25 ml aliquots at -20 aC.
Labelled albumin was stored in 0·1 ml aliquots at -20°C. For use an aliquot was diluted with 20 m1 of 0·1 rnol/l tris buffer, pH 8·7.
Labelled antiserum was stored at 4"C and diluted 1 in 4 with O·1 mol/I tris buffer, pH 8·7, for use.
To 2·5 ml round-bottomed polystyrene tubes were added 0·1 ml standard or diluted sample and 0·1 ml labelled albumin. The tubes were mixed and 0·1 ml labelled antiserum was added. The tubes were mixed again and incubated in the dark for 2 to 4 hours at room temperature. One millilitre of 0·1 mol/l tris buffer, pH 8·7, was added to each tube and the reaction mixtures were transferred to analyser cups for dilution and measurement of fluorescence as described above.
Albumin concentrations were measured in plasma samples from the routine workload ofthe laboratory. Plasma samples were diluted 1 in 400 in 0·1 mol/I phosphate buffer, pH 7, for assay.
Peak heights were measured manually, and the data were processed using a four-parameter iterative curve-fitting program" on an Olivetti P6060 microcomputer (British Olivetti Ltd, 30 Berkeley Square, London W1X 6AH) for calculation of the results.
Results were compared with those given by a manual dye-binding method using bromocresol purple, similar to that described by Carter.P For this, 10 ILl plasma was mixed with 3 m1 of a reagent containing per litre: 0·09 g bromocresol purple; 2 ml glacial acetic acid; 4 ml absolute ethanol; 6·12 g sodium acetate trihydrate; and 3·6 ml 30 % w/v 'Brij' 35. The absorbance of the mixture was measured at 603 nm against a blank containing all the components apart from the dye. A standard curve was prepared by dilution from a 50 g/I solution of human albumin in 0·1 mol/I phosphate buffer, pH 7. 
Discussion
The use of fluorescent labels offers the prospect of irnmunoassays that are as sensitive as radioimmunoassays but which can be easily automated because no separation step is required. In practice, however, the properties of the most commonly used labelfluorescein-are such that considerable interference is caused in homogeneous imrnunoassays by the presence of serum or plasma. Consequently, those fluoroimmunoassays that have very high sensitivity have invariably been heterogeneous assays, usually employing one component bound to a solid support such as polyacrylamide beads. In this way it is made possible for those components of the sample that are not of interest to be removed by washing, so that the measurement of fluorescent intensity is carried out in the absence of sample. Homogeneous fluoroimmunoassays require that this measurement be made in the presence of all the sample material originally added, and if fluorescein is the label used, the interference from the intrinsic fluorescence of serum or plasma constituents, and frcm scattered light, limit the sensitivity available. In the case of ETIA, the use of fluorescein is attended by an additional difficulty, in that the second fluorophore can be excited directly at 495 nm. This results in a high background at the wavelength of maximum emission of the second fluorophore.
Under the conditions of the assay described here, sample blanks containing no labelled species showed no detectable fluorescence above the baseline given by the diluent alone. The limit of detection, calculated as the concentration corresponding to two standard deviations of the fluorescence intensity at zero albumin concentration, is about 2 gil. This is equivalent to a concentration in the flowcell of about 0·5 mgll. The assay is comparable in sensitivity to previously described assays using fluoresceinlabelled albumin.s I? Nargessi, Landon, and Smiths used fluorescein-labelled albumin in an indirect quenching immunoassay and prepared sample blanks to correct for the intrinsic fluorescence of serum. Lim, Miller, and Brldges'? used fluoresceinlabelled albumin and rhodamine-labelled antibodies in an energy transfer immunoassay. Rhodamine B, although it has the required spectral overlap with Lucifer yellow VS, is not ideal as the second label, since it can be directly excited at 430 nm. Because it also has only a small Stokes shift, some emission is detectable at 540 nm. In practice, the background emission at 540 nm was acceptable in this assay, although measurement of fluorescence enhancement at 580 nm was not considered worthwhile because of the high background at this wavelength.
In conclusion then, we have shown that the fluorescence of Lucifer yellow VS can be quenched by a suitable acceptor molecule and that it is possible to use this effect in an energy transfer immunoassay. With rhodamine B as the acceptor, it is possible to achieve sensitivity comparable to that attainable with a fluorescein label, while eliminating the need to prepare sample blanks. With a more suitable quencher, it should be possible to develop highly sensitive homogeneous fluoroimmunoassays for both small molecules and proteins.
